Over the past year there were no insider purchases at Centessa Pharmaceuticals plc. Five insiders sold roughly $16.5 million instead.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Anderson Karen M. | Executive Officer | Sell | 41,076 | $30.12 | $1.2M | SEC |
| Mar 26, 2026 | Weinhoff Gregory M | Executive Officer | Sell | 23,998 | $30.00 | $720K | SEC |
| Mar 18, 2026 | Anderson Karen M. | Executive Officer | Sell | 10,043 | $28.10 | $282K | SEC |
| Mar 18, 2026 | Anderson Karen M. | Executive Officer | Sell | 64,768 | $28.21 | $1.8M | SEC |
| Mar 16, 2026 | Anderson Karen M. | Executive Officer | Sell | 107,961 | $26.15 | $2.8M | SEC |
| Mar 16, 2026 | Anderson Karen M. | Executive Officer | Sell | 12,068 | $27.13 | $327K | SEC |
| Mar 13, 2026 | Anderson Karen M. | Executive Officer | Sell | 107,961 | $26.15 | $2.8M | SEC |
| Mar 13, 2026 | Anderson Karen M. | Executive Officer | Sell | 12,068 | $27.13 | $327K | SEC |
| Mar 13, 2026 | Weinhoff Gregory M | Executive Officer | Sell | 11,943 | $27.16 | $324K | SEC |
| Mar 13, 2026 | Weinhoff Gregory M | Executive Officer | Sell | 61,253 | $26.17 | $1.6M | SEC |
| Feb 3, 2026 | HUSSAIN IQBAL J | Executive Officer | Sell | 1,010 | $25.01 | $25K | SEC |
| Feb 3, 2026 | HUSSAIN IQBAL J | Executive Officer | Sell | 38,951 | $25.15 | $980K | SEC |
| Dec 9, 2025 | Accardi Mario Alberto | President | Sell | 7,432 | $28.70 | $213K | SEC |
| Dec 9, 2025 | Accardi Mario Alberto | President | Sell | 2,568 | $29.21 | $75K | SEC |
| Dec 8, 2025 | Accardi Mario Alberto | President | Sell | 10,000 | $30.00 | $300K | SEC |
In the last 12 months Centessa Pharmaceuticals plc insiders made open-market purchases worth about $0 and sales worth about $16.5 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CNTA was filed on 2026-03-27.
No congressional trades in CNTA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).